{"database": "lobbying", "table": "lobbying_activities", "rows": [[3247011, "0cb08338-799c-4f5b-a5d6-eeaf4ed225a5", "Q3", "NATIONAL PORK PRODUCERS COUNCIL", 28355, "NATIONAL PORK PRODUCERS COUNCIL", 2024, "third_quarter", "ANI", "U.S. Food and Drug Administration Draft Guidance for Industry #187, Regulation of Intentionally Altered Genomic DNA in Animals, to address animals with intentionally altered genomic DNA developed through use of genome editing technologies, as well as techniques such as rDNA in genetic engineering. Regulation of the Movement of Animals Modified or Developed by Genetic Engineering; RIN 0579-AE60; December 28, 2020; 85 CFR 84269. General education regarding the global spread of African Swine Fever and its possible ramifications to the U.S. pork industry, including the potential impact of imported dogs from ASF positive countries. Impact of California Proposition 12, Farm Animal Confinement Initiative (2018), on the pork industry. Seeking additional funding for National Animal Health Laboratory Network, the National Animal Vaccine and Countermeasures Bank, the National Animal Disease Preparedness and Response Program, and National Veterinary Stockpile. General education on the ASF outbreak on the island of Hispaniola and the need to ensure that USDA and CBP have sufficient resources to keep ASF out of Puerto Rico and the U.S. mainland. General education on Agricultural Quarantine Inspection (AQI) user fee reductions and the need for additional Customs and Border Protection agricultural inspectors. S.759/H.R. 1480 - Beagle Brigade Act of 2023, all provisions. S.2019/H.R. 4417 - Ending Agricultural Trade Suppression Act. S.1666/H.R. 3419 - Foreign Animal Disease Prevention, Surveillance, and Rapid Response Act of 2023. S.4690/H.R.9027 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2025. S.1844/H.R. 1418 - Animal Drug and Animal Generic Drug User Fee Amendments of 2023. Oversight urging the FDA to conduct an evidentiary hearing as governed by 21 U.S.C 360(e)(1)(B) and 21 C.F.R. Part 12 before removing any approved drug from the market.", "Agriculture, Dept of (USDA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,U.S. Customs & Border Protection", null, 660000, 0, 0, "2024-10-18T09:05:42-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3247011"], "units": {}, "query_ms": 36.99015988968313, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}